Market overview
The global single use bioreactor market is worth USD 6.2 bn in 2026 and is forecast to reach USD 19.1 bn by 2036, growing at a 12.0% CAGR. United States is the largest country market and Bioreactor bags and assemblies is the largest by product segment.
| Scope | Single-use bioreactor systems and disposable bags with sensors and accessories used to culture cells for biologics, vaccines and cell and gene therapy. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 5.5 bn |
| Value 2026 | USD 6.2 bn |
| Value 2036 | USD 19.1 bn |
| CAGR 2026-2036 | 12.0% |
| Volume 2026 | 1,672 thousand units |
| Volume 2036 | 4,939 thousand units |
| Average price 2026 | USD 3,685 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Single Use Bioreactor market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 6.2 bn |
| 2027 | USD 6.9 bn |
| 2028 | USD 7.7 bn |
| 2029 | USD 8.7 bn |
| 2030 | USD 9.7 bn |
| 2031 | USD 10.9 bn |
| 2032 | USD 12.2 bn |
| 2033 | USD 13.6 bn |
| 2034 | USD 15.3 bn |
| 2035 | USD 17.1 bn |
| 2036 | USD 19.1 bn |
Single Use Bioreactor market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Bioreactor bags and assemblies | 58.0% | 58.6% | USD 3.6 bn | 12.1% |
| Bioreactor systems | 28.0% | 25.9% | USD 1.7 bn | 11.1% |
| Sensors and accessories | 14.0% | 15.5% | USD 862 mn | 13.1% |
By scale
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Process development | 26.0% | 24.0% | USD 1.6 bn | 11.1% |
| Clinical manufacturing | 30.0% | 31.6% | USD 1.8 bn | 12.6% |
| Commercial manufacturing | 44.0% | 44.4% | USD 2.7 bn | 12.1% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Biopharmaceutical companies | 62.0% | 60.1% | USD 3.8 bn | 11.7% |
| Contract manufacturers | 26.0% | 28.8% | USD 1.6 bn | 13.2% |
| Academic and research | 12.0% | 11.1% | USD 739 mn | 11.2% |
By working volume
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Bench scale | 28.0% | 24.0% | USD 1.7 bn | 10.3% |
| Pilot scale | 30.0% | 28.0% | USD 1.8 bn | 11.2% |
| Production scale | 30.0% | 32.0% | USD 1.8 bn | 12.7% |
| Large scale | 12.0% | 16.0% | USD 739 mn | 15.3% |
By material
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Polyethylene | 62.0% | 60.0% | USD 3.8 bn | 11.6% |
| EVA multilayer | 22.0% | 20.0% | USD 1.4 bn | 10.9% |
| Others | 16.0% | 20.0% | USD 986 mn | 14.5% |
Top 25 countries for single use bioreactor by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 87.0% of 2026 revenue and the 25 countries below together hold 96.3%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 2.3 bn | 38.0% | USD 6.9 bn | 11.5% |
| 2 | Germany | USD 554 mn | 9.0% | USD 1.6 bn | 11.0% |
| 3 | China | USD 554 mn | 9.0% | USD 2.3 bn | 15.5% |
| 4 | Switzerland | USD 370 mn | 6.0% | USD 1.1 bn | 11.4% |
| 5 | Ireland | USD 308 mn | 5.0% | USD 918 mn | 11.5% |
| 6 | United Kingdom | USD 308 mn | 5.0% | USD 918 mn | 11.5% |
| 7 | Japan | USD 246 mn | 4.0% | USD 670 mn | 10.5% |
| 8 | South Korea | USD 246 mn | 4.0% | USD 880 mn | 13.6% |
| 9 | Singapore | USD 246 mn | 4.0% | USD 804 mn | 12.6% |
| 10 | France | USD 185 mn | 3.0% | USD 555 mn | 11.6% |
| 11 | Canada | USD 128 mn | 2.1% | USD 381 mn | 11.5% |
| 12 | Spain | USD 76 mn | 1.2% | USD 226 mn | 11.4% |
| 13 | Italy | USD 56 mn | 0.9% | USD 166 mn | 11.5% |
| 14 | Netherlands | USD 46 mn | 0.7% | USD 134 mn | 11.4% |
| 15 | Belgium | USD 38 mn | 0.6% | USD 115 mn | 11.6% |
| 16 | Denmark | USD 33 mn | 0.5% | USD 99 mn | 11.6% |
| 17 | Sweden | USD 30 mn | 0.5% | USD 88 mn | 11.5% |
| 18 | India | USD 27 mn | 0.4% | USD 113 mn | 15.3% |
| 19 | Taiwan | USD 25 mn | 0.4% | USD 73 mn | 11.4% |
| 20 | Australia | USD 23 mn | 0.4% | USD 67 mn | 11.4% |
| 21 | Israel | USD 21 mn | 0.3% | USD 90 mn | 15.7% |
| 22 | Austria | USD 20 mn | 0.3% | USD 59 mn | 11.6% |
| 23 | Brazil | USD 18 mn | 0.3% | USD 78 mn | 15.6% |
| 24 | Mexico | USD 18 mn | 0.3% | USD 75 mn | 15.4% |
| 25 | Thailand | USD 17 mn | 0.3% | USD 71 mn | 15.6% |
| Rest of world | USD 225 mn | 3.7% | USD 614 mn | 10.5% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Sartorius
- Thermo Fisher Scientific
- Cytiva
- Merck KGaA
- Eppendorf
- Pall Corporation
Group 2: Regional and specialist players
- Corning
- Getinge
- PBS Biotech
- Applikon
- ABEC
- Kuhner
- Infors HT
- Esco Lifesciences
Group 3: Emerging and niche players
- Distek
- Cellexus
- Solida Biotech
- Cesco Bioengineering
- Bailun Biotechnology
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the single use bioreactor market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 12.0% is calculated from the resulting values.
The market is divided by product, by scale, by end user, by working volume, by material. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the single use bioreactor market?
The global single use bioreactor market is estimated at USD 5.5 bn in 2025 and USD 6.2 bn in 2026.
How fast will the single use bioreactor market grow?
It is forecast to reach USD 19.1 bn by 2036, a compound annual growth rate of 12.0% from 2026, an increase of USD 13.0 bn.
Which country is the largest market for single use bioreactor?
United States is the largest market by revenue at USD 2.3 bn in 2026, 38.0% of the global total. The three largest countries together hold 56.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 15.5% a year from 2026 to 2036.
Which single use bioreactor segment is largest?
In the by product split, Bioreactor bags and assemblies is the largest segment with 58.0% of 2026 revenue.
Who are the leading single use bioreactor companies?
Global leaders include Sartorius, Thermo Fisher Scientific, Cytiva, Merck KGaA.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Artificial Pancreas DeviceUSD 6.2 bn · 12.5% CAGR
- Good Manufacturing Practice ComplianceUSD 6.3 bn · 8.5% CAGR
- Tissue EngineeringUSD 6.0 bn · 10.5% CAGR
- Liquid HandlingUSD 6.0 bn · 7.5% CAGR
- Retail ClinicUSD 6.3 bn · 5.3% CAGR
- Cleanroom EquipmentUSD 6.0 bn · 8.0% CAGR
- Microsphere Drug DeliveryUSD 6.0 bn · 8.0% CAGR
- UltrafiltrationUSD 6.4 bn · 9.5% CAGR